Delivery Order SPE2DB22D3010-SPE2DB24FP2PK
Award Date
6/7/24
Potential Completion Date
6/10/24
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a ceiling value of $3,796.20 and a period of performance through September 13, 2024. This contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,021.76 firm-fixed price contract is for the supply of 4,565,913,991 units of the BOOSTRIX TDAP vaccine syringe 0.5 mL. The contract has an ultimate completion date of September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The award has a ceiling value of $36,781.92 and a period of performance through May 15, 2024. It is a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Boostrix TDAP vaccine syringes. The contract has a ceiling value of $24,472.32 and runs through February 24, 2023. It is a firm-fixed-price contract type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,570,475 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a ceiling value of $11,899.50. The delivery order has a firm fixed price and an ultimate completion date of February 6, 2024. The contract was awarded on February 5, 2024, and there was no set-aside designation used. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $20,246.40 firm-fixed-price contract is for the supply of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product, with a completion date of August 14, 2024. Amerisourcebergen is a leading pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including medications, vaccines, and medical supplies, to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP vaccine syringes. The contract has a firm fixed price of $2,659.10 and a completion date of November 27, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BOOSTRIX TDAP vaccine syringes, a critical medical product used for infectious disease prevention. The contract has a firm fixed price of $9,572.76 and a completion date of November 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $3,103.44 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to supply the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This contract has a completion date of March 5, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is likely part of a larger indefinite delivery contract (IDC) with DLA valued up...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract, valued at $1,603.98, has a completion date of February 2, 2024 and was awarded on February 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...